BENCHMARKS REPORT
Industry Measure: Business Segment Data
| SIC: | 2836 |
| INDUSTRY: | BIOLOGICAL PRODUCTS (EXC DIAGNOSTIC) |
| BENCHMARKS FOR THE INDUSTRY |
| NO. OF SEGMENTS REPORTING IN THE INDUSTRY: 111 |
|
1997 SALES FOR THE INDUSTRY: $ 5594 (Total Sales in $Millions) |
|
OPERATING MARGIN: 1.1 (Allocated Operating Profits (divided by) Segment Sales) |
|
ASSET INTENSITY: 204.1 (Allocated Assets (divided by) Segment Sales) |
|
SALES GROWTH: 36.4 (Compound 3-Year Growth Rate in Sales for the Median Participant in the Industry) |
| BENCHMARKS FOR THE TOP FOUR COMPETITORS |
| ROA: Allocated Operating Profits (divided by) Allocated Operating Assets |
| Competitor/Rank by Sales |
Market Share (% Ind. Sales) |
ROA |
| #1: AMGEN INC |
42.9 | 31.7 |
| #2: GENZYME GENERAL |
10.7 | 10.4 |
| #3: BIOGEN INC |
7.4 | 15.5 |
| #4: CAMBREX CORP |
6.6 | 12.9 |
| Total of #1-4: | 67.5 | 0.5 |